News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mirna Therapeutics, Inc. Presents New Data on the Development of miRNA-based Therapeutic Candidates for Hepatocellular Carcinoma


11/15/2011 6:58:17 AM

AUSTIN, Texas--(BUSINESS WIRE)--Mirna Therapeutics, Inc., a biotechnology company pioneering microRNA replacement therapy for cancer, announced the presentation today of new preclinical data on the development of a miRNA-based therapeutic candidate for primary liver cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in San Francisco, CA. The data were simultaneously presented at the 2011 CPRIT Innovations in Cancer Prevention and Research Conference in Austin, TX.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES